Salvatore, Sofia V.
Ilagan, Ma. Xenia G.
Shu, Hongjin
Lambert, Peter M.
Benz, Ann
Qian, Mingxing
Covey, Douglas F.
Zorumski, Charles F.
Mennerick, Steven
Funding for this research was provided by:
National Institute of Mental Health (MH123748, MH126548, MH122379, MH122379)
Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine in St. Louis
Article History
Received: 18 July 2023
Accepted: 7 January 2024
First Online: 10 January 2024
Competing interests
: CFZ is a member of the Scientific Advisory Board for Sage Therapeutics and holds equity in Sage Therapeutics. DFC was a co-founder of Sage Therapeutics and holds equity in Sage Therapeutics. Sage Therapeutics had no role in the design or interpretation of the experiments herein. The remaining authors have nothing to disclose.